Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    OncoCyte Corporation

    NASDAQ: OCX · Real-Time Price · USD
    3.20
    0.47 (17.22%)
    At close: Jun 17, 2025, 3:59 PM

    OncoCyte Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.88M 1.5M 958K 7.73M
    Cost of Revenue
    		 1.14M 1.09M 976K 7.54M
    Gross Profit
    		 740K 413K -18K 188K
    Operating Income
    		 -61.04M -25.14M -18M -46.95M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -60.66M -24.86M -18.61M -73.36M
    Net Income
    		 -60.66M -27.78M -73.44M -64.1M
    Selling & General & Admin
    		 14.15M 13.54M 23.01M 33.5M
    Research & Development
    		 9.84M 9.29M 7.3M 13.63M
    Other Expenses
    		 38.16M 2.72M -67K -37K
    Operating Expenses
    		 60.64M 25.64M 30.31M 47.13M
    Interest Expense
    		 84K 52K 83K 209K
    Selling & Marketing Expenses
    		 3.94M 2.79M 1.13M 11.17M
    Cost & Expenses
    		 61.78M 26.64M 31.29M 54.67M
    Income Tax Expense
    		 n/a n/a n/a -9.26M
    Shares Outstanding (Basic)
    		 13.07M 7.65M 5.54M 4.45M
    Shares Outstanding (Diluted)
    		 13.07M 7.65M 5.54M 4.45M
    EPS (Basic)
    		 -4.66 -3.75 -13.26 -14.42
    EPS (Diluted)
    		 -4.66 -3.75 -13.26 -14.42
    EBITDA
    		 -59.02M -23.12M -13.31M -48.46M
    EBIT
    		 -60.58M -24.8M -18.53M -52.66M
    Depreciation & Amortization
    		 1.56M 1.68M 5.22M 4.21M

    Add to Watchlist